ASX listed entities report substantial R&D Tax Offsets in recent months

January 16th, 2023

A number of Australian companies have reported substantial Refundable R&D Tax Offset receipts in recent months, including:

  • Starpharma received a refund of $7.1M for FY22 R&D activity to progress three clinical-stage assets;
  • ClearVue Technologies received a refund of $0.81M for FY22 R&D activity to progress its clean energy technologies;
  • Estrella resources a refund of $1.01M for FY22 R&D activity related to its Carr Boyd Nickel project;
  • Emyria received a refund of $2.1M for FY22 R&D Activity to support the registration of its treatment its CBD Capsule product, EMD-RX5;
  • Pharmaxis received a refund of $4.9M for FY22 R&D activity to progress the company’s clinical development pipeline for multiple treatments;
  • Aruma Resources received a refund of $0.83M for FY22 R&D activity in respect of the company’s mineralisation model incorporating volcanic ash sequences project;

Receipt of refundable R&D tax offsets reduces the need for a companies to raise additional capital to complete development of their technology, and makes pathway to commercialisation exponentially easier.

In an environment of rising interest rates and lower share prices for emerging entities, it becomes more difficult for start up companies to raise capital. The R&D Tax Incentive becomes an even more important source of funding for such companies in these times.

 

Please get in touch with our office if you would like to speak to someone about a potential  R&D claim, or check out our website for more information.

Post a Comment

(*) indicates required field.

Categories

Archives

Swanson Reed - Specialist R&D Tax Advisors
Swanson Reed - Specialist R&D Tax Advisors
39 Google reviews
Daniel McGregor
Daniel McGregor
2022-08-11
I have been using Swanson Reed for my clients for more than a decade. Having a specialist firm that can provide practical and commercial advice that produces real outcomes is very important and we have received great feedback from our clients. Highly recommended.
John
John
2022-06-15
Damian and the rest of the team at Swanson Reed have been supporting us for several years. We always appreciate their insights, expertise, and efforts.
Rueben Rajasingam
Rueben Rajasingam
2022-06-06
Experienced responsive Team. They have been a great help to me and my company navigate the R&D tax claim process and have provided invaluable advice.
Enrique Esquivel
Enrique Esquivel
2022-06-06
Damian and the team at Swanson Reed have been extremely helpfully and professional during all of our consultations. Highly recommended.
Jess at Y&C
Jess at Y&C
2022-06-03
Anatole Kononewsky
Anatole Kononewsky
2022-06-02
The Swanson Reed team have provided our company with exceptional professional advice and assistance for all of our R&D claims for many years - have always achieved great results with excellent value for their services.
Payam Toloo
Payam Toloo
2022-06-02
Damian Smyth and his team are very helpful, supportive and experts in their field of R&D Tax claims. I'm always happy with the work they do and been a customer of their for over 5 years.
Melissa Doddy
Melissa Doddy
2022-05-31
The Team at Swanson Reed are very experienced R&D Tax Advisors and gave us ongoing support with all of our R&D Claims, the consultants ensured we were always working with current legislative guidelines, gave us assistance with compiling technical and government documentation and went out their way to ensure they were with us for the entire process from beginning to end. Highly recommended to anyone who needs assistance with working through what can at times be a daunting process.
Gary Watson
Gary Watson
2022-05-31
We can highly recommend Swanson and Reed as an R & D accountant. We have worked with them for several years now as they make our R & D claim so easy and communicate quickly with both us and our accountant.
Rob van den Bergh
Rob van den Bergh
2022-05-31
Always professional.